Financhill
Back

Cognition Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

CGTX
Cognition Therapeutics, Inc.

Last Price:
$1.47
Seasonality Move:
24.89%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Cognition Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.55 Sell
20-day SMA: 1.62 Sell
50-day SMA: 1.64 Sell
200-day SMA: 1.06 Buy
8-day EMA: 1.55 Sell
20-day EMA: 1.59 Sell
50-day EMA: 1.61 Sell
200-day EMA: 1.28 Buy

Cognition Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 43.6 Sell
Chaikin Money Flow: 303523 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.45 - 1.71) Sell
Bollinger Bands (100): (1.24 - 2.16) Sell

Cognition Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cognition Therapeutics, Inc. Stock

Is Cognition Therapeutics, Inc. Stock a Buy?

CGTX Technical Analysis vs Fundamental Analysis

Sell
42
Cognition Therapeutics, Inc. (CGTX) is a Sell

Is Cognition Therapeutics, Inc. a Buy or a Sell?

Cognition Therapeutics, Inc. Stock Info

Market Cap:
128.9M
Price in USD:
1.46
Share Volume:
425.2K

Cognition Therapeutics, Inc. 52-Week Range

52-Week High:
3.83
52-Week Low:
0.22
Sell
42
Cognition Therapeutics, Inc. (CGTX) is a Sell

Cognition Therapeutics, Inc. Share Price Forecast

Is Cognition Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Cognition Therapeutics, Inc.

Is Cognition Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.06 per share.

Technical Analysis of Cognition Therapeutics, Inc.

Should I short Cognition Therapeutics, Inc. stock?

* Cognition Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.